← All organizations
Highest phase reached
Phase 2
First clinical trial
May 21, 2023Last known activity
May 21, 2023
Timeline
2010s
- Jan 1, 2017
Grey Wolf Therapeutics— Founded
Drugs by trial phase (2 distinct, 1 trials)
Phase 2 (2 own, 0 via acquisition)
Recent trials (1)
- NCT06923761Lead sponsorPhase 1/Phase 2May 21, 2023
Details
- Founded
- Oxford, GB Jan 1, 2017
- Last known activity
- May 21, 2023